期刊文献+

艾滋病疗法的评价及疗效的预测 被引量:4

Study on curative effect prediction and therapy assessment of AIDS
下载PDF
导出
摘要 在美国艾滋病医疗试验机构ACTG公布的两组数据ACTG320和193A的基础上,利用随机过程理论及数理统计分析方法进行了研究:首先给出了数据ACTG320按时间序列是一个其断面数据服从正态分布的随机过程的判断,通过数据拟合方法讨论了CD4浓度的对数型均值时间序列LCD4(t)和HIV浓度均值时间序列HIV(t)的变化关系、相应的显著性检验及它们的相关性分析,给出了治疗的最佳终止时间的模型研究;其次在数据193A的基础上,进行了4种治疗方案的对数型CD4均值增量与时间t的关系变化研究,及相应治疗方案最佳终止时间的确定;最后建立了治疗效果的综合评价模型,就193A提供的4种治疗方案给出了综合评价。 In this paper,on the basis of data ACTG320 and 193A provided by ACTG,it is given that the study on curative effect prediction and therapy assessment of AIDS by using stochastic process theory and statistic analysis methods.It consists of first,giving the discrimination that data ACTG320 according to time series is a stochastic process obeying by normal distribution on cross face,discusslng changeable relations of mean time series LCD4 (t) and HIV (t) by quadratic fit and their correlation analysis which is highly significant,and getting the optimal stop-time model of a therapy;Second,on the basis of data 193A,investigating changeable relations of logarithmic type data(i.e.Ln(CD4+1)) means time series of four therapies with time t respectively and determining their optimal stop-time;finally,setting up the comprehensive assessment model of treatment affect and giving the comprehensive assessment of four therapies in data 193A.
机构地区 江南大学理学院
出处 《计算机工程与应用》 CSCD 北大核心 2007年第35期175-178,共4页 Computer Engineering and Applications
基金 国家重点基础研究发展规划(973)( the National Grand Fundamental Research 973 Program of China under Grant No.2002CB111400) 教育部博士点基金( No.200403057002) 科技部国际科技合作项目( No.2006DF2230)
关键词 随机过程 相关性分析 数据拟合 显著性检验 优化目标函数 stochastic process correlation analysis curve fitting significant tests optimal objective function
  • 相关文献

参考文献14

二级参考文献45

  • 1黄世敬,危剑安,曹惠云,孙利民,游秀珍,苏小游,黄霞珍,苏诚练,许铣,李国勤,刘国,王健,吕维柏,于智敏,那奥米,夏邬丽.中医辨证治疗艾滋病729例临床观察[J].中医杂志,2004,45(9):680-682. 被引量:27
  • 2杨凤珍,李洪娟,李峰,关静,赵丹,王健,刘颖.218例HIV/AIDS患者中医舌象分析及其病机探讨[J].中国中医基础医学杂志,2004,10(11):48-49. 被引量:15
  • 3周伟,危剑安,孙利民,黄霞珍,陈宇霞,宋春鑫.AIDS的高效抗逆转录病毒疗法的毒副作用[J].中国艾滋病性病,2005,11(1):73-75. 被引量:31
  • 4[1]Carr A, Samaras K, Burton S, et al. A syndrome of peripheral lipodystrophy,hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors. AIDS, 1998,12 (7): F51-F58. 被引量:1
  • 5[2]Katzenstein D. Adherence as a particular issue with protease inhibitors.Journal of the Association of Nurses AIDS Care, 1997,8( Suppl ) :s10-s17. 被引量:1
  • 6[3]Deeks SG, Smith M, Holodniy M, et al. H1V-1 protease inhibitors. A review for clinicians. Journal of the American Medical Association, 1997,277(2) :145-153. 被引量:1
  • 7[4]Scaling up antiretroviral therapy in resource-limited settings:guidelines for a public health approach. AIPAC Mom,2002,8(6) ,168 - 175. 被引量:1
  • 8[5]Cheeseman SH, Hattox SE, McLaughlin MM, et al. Pharmacokinetics of nevirapine: initial singlerising- dose study in humans. Antimicrobial Agents and Chemotherapy, 1993,37 (2): 178-182. 被引量:1
  • 9[6]Raffil F, Reliquet V,Ferrel V, et al. The VIRGO Study: nevirapine, didanosine and stavudine combination therapy in antiretroviral-na? ve HIV-l-infected adults. Antiviral Therapy,2000,5 (4) :267-272. 被引量:1
  • 10[7]Spruance SL,Pavia AT,Mellors JW,et al. Clinical efficacy of monotherapy with stavudine compared with zidovudine in HIV-infected, zidovudine-experienced patients. Annals of Internal Medicine, 1997,126 ( 5 ):355 -363. 被引量:1

共引文献38

同被引文献30

引证文献4

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部